Abstract | BACKGROUND: CONCLUSION:
|
Authors | Toshihiro Fukushima, Hiroshi Kawabata, Takuji Nakamura, Haruka Iwao, Akio Nakajima, Miyuki Miki, Tomoyuki Sakai, Toshioki Sawaki, Yoshimasa Fujita, Masao Tanaka, Yasufumi Masaki, Yuko Hirose, Hisanori Umehara |
Journal | Anticancer research
(Anticancer Res)
Vol. 31
Issue 5
Pg. 1741-4
(May 2011)
ISSN: 1791-7530 [Electronic] Greece |
PMID | 21617233
(Publication Type: Case Reports, Journal Article)
|
Chemical References |
- Aminoglycosides
- Antibodies, Monoclonal
- Antibodies, Monoclonal, Humanized
- Antineoplastic Agents
- Benzoates
- Iron Chelating Agents
- Triazoles
- Gemtuzumab
- Deferasirox
|
Topics |
- Aged
- Aminoglycosides
(adverse effects)
- Antibodies, Monoclonal
(adverse effects)
- Antibodies, Monoclonal, Humanized
- Antineoplastic Agents
(adverse effects)
- Benzoates
(therapeutic use)
- Chelation Therapy
- Deferasirox
- Drug Resistance, Neoplasm
(drug effects)
- Erythrocyte Transfusion
- Gemtuzumab
- Humans
- Iron Chelating Agents
(therapeutic use)
- Leukemia, Myelomonocytic, Acute
(drug therapy)
- Male
- Remission Induction
- Salvage Therapy
- Treatment Outcome
- Triazoles
(therapeutic use)
|